首页> 外文期刊>European journal of health law >Preimplantation Genetic Diagnosis: The Situation in France and in Other European Countries
【24h】

Preimplantation Genetic Diagnosis: The Situation in France and in Other European Countries

机译:遗传遗传诊断:法国和其他欧洲国家的情况

获取原文
获取原文并翻译 | 示例
       

摘要

Preimplantation genetic diagnosis (pgd) relates exclusively to in vitro fertilisation techniques (ivf) that aim to prevent transmission of a serious genetic abnormality to the child. The genetic characteristics of the embryo created through ivf are analysed, and only the embryos free of the genetic abnormality are implanted in the womb. Performed worldwide since 1990, this technique has raised many legal and ethical debates due to the very wide variations of lawgiving between countries. This is shown by the report of the unesco ibc (2003), which described the techniques and the issues raised by preimplantation genetic diagnosis. In this article, the authors present the differences between prenatal diagnosis and preimplantation genetic diagnosis, the French legislation, then the range of legislation in Europe and finally the position of the European Court of Human Rights which sanctioned Italy and Latvia for refusing access to pgd.
机译:Preclantation遗传诊断(PGD)仅涉及体外施肥技术(IVF),其目的是防止对孩子传播严重的遗传异常。 分析通过IVF产生的胚胎的遗传特征,并且在子宫内仅植入无遗传异常的胚胎。 自1990年以来在全球范围内完成,由于各国之间的律师的广泛变化,这种技术已经提出了许多法律和道德辩论。 这是由联合国教科文组织IBC(2003)的报告显示的,该报告描述了通过预催化遗传诊断提出的技术和问题。 本文在本文中,提出了产前诊断和预体遗传诊断的差异,法国立法,然后是欧洲的立法范围,最后是欧洲人权法院的立场,这些人权法院制裁意大利和拉脱维亚拒绝进入PGD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号